Using a Connected Application to Maintain Physical Activity After Cardiac Rehabilitation

NCT ID: NCT05646849

Last Updated: 2024-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

208 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-12

Study Completion Date

2026-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Maintaining physical activity after cardiac rehabilitation has a major role in disease progression and patient prognosis. 6 months after the cardiac rehabilitation, we find during a nursing interview that many patients do not maintain regular physical activity.

1 year after cardiac rehabilitation, between 30% and 60% of patients do not maintain the recommendations in terms of physical activity.

It is recommended to perform studies evaluating the effectiveness of new technologies in the fight against non-compliance recommendations for physical activity.

That is why, study the interest of using an application connected post-cardiac rehabilitation seems necessary to fight against dropouts in terms of physical activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective is to study compliance with the recommendations, assessed by accelerometer at 6 months post-cardiac rehabilitation within two groups : classic care versus using a connected application.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Rehabilitation Acute Coronary Syndrome Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Classic care

Home exercise book, personalized advices and development of an individualized project post-cardiac rehabilitation.

Group Type NO_INTERVENTION

No interventions assigned to this group

Connected application

Recording and sharing sessions. Exchanges and interactions with other patients. Participation in three collective challenges.

Group Type EXPERIMENTAL

Connected application

Intervention Type OTHER

Recording and sharing sessions. Exchanges and interactions with other patients. Participation in three collective challenges.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Connected application

Recording and sharing sessions. Exchanges and interactions with other patients. Participation in three collective challenges.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient participating in cardiac rehabilitation
* Patient with a smartphone compatible with the application
* Patient with internet connection
* Patient having signed the written consent to participate

Exclusion Criteria

* Patient reluctant or unable to comply with the protocol
* Pregnant, parturient and nursing mothers
* Persons deprived of their liberty or under guardianship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul Da Ros Vettoretto

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier de Cholet

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ch Cholet

Cholet, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marie Gaume

Role: CONTACT

+33241496000

DRCI CHU Angers

Role: CONTACT

+33241356329

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

YOUNA GOURRONC, DR

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A01974-39

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.